Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing program.
about
Self-Assembled Bifunctional Peptide as Effective Drug Delivery Vector with Powerful Antitumor Activity.Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program.Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.Identifying novel therapeutic agents using xenograft models of pediatric cancer.
P2860
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing program.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Initial testing (stage 1) of t ...... c preclinical testing program.
@ast
Initial testing (stage 1) of t ...... c preclinical testing program.
@en
type
label
Initial testing (stage 1) of t ...... c preclinical testing program.
@ast
Initial testing (stage 1) of t ...... c preclinical testing program.
@en
prefLabel
Initial testing (stage 1) of t ...... c preclinical testing program.
@ast
Initial testing (stage 1) of t ...... c preclinical testing program.
@en
P2093
P2860
P50
P356
P1476
Initial testing (stage 1) of t ...... ic preclinical testing program
@en
P2093
E Anders Kolb
Jianrong Wu
John M Maris
Peter J Houghton
Raushan T Kurmasheva
P2860
P304
P356
10.1002/PBC.25611
P577
2015-07-07T00:00:00Z